QHSLab reports fiscal 2025 net income of $457K, revenue up 26% to $2.69M

QHSLab, Inc.

2026-Q1 EPS reported $0.00 revenue$728,685

Revenue $2.69M (+26% YoY); net income $457,417 vs net loss $259,239 in 2024.
Gross margin expanded to 67.3% from 63.7%; gross profit $1.81M vs $1.36M.
Current liabilities reduced to ~$450K from ~$2.4M; cash increased to $636K from $157K.
ISP revenue grew 74% YoY to $1.12M; immunotherapy sales up ~19%.
Recorded ~$1.15M gain on extinguishment of convertible debt; interest expense halved to $237K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.